FrancophonIA/ELRC3.0 huggingface dataset:
English: - Intercurrent events, in particular dehydratation, acute cardiac decompensation, metabolic acidosis, worsening of renal function, sudden worsening of the renal condition (e.g. infectious diseases), cellular lysis (e.g. acute limb ischemia, rhabdomyolysis, extend trauma).
Slovenian: poslabšanje ledvičnega delovanja, nenadno poslabšanje ledvične bolezni (na primer infekcijske bolezni), celična liza (na primer akutna ishemija uda, rabdomioliza, obsežna poškodba).
English: Pritor 40 mg tablets
Slovenian: Pritor 40 mg tablete
English: • Medicines that may increase blood potassium levels such as salt substitutes containing potassium, potassium-sparing diuretics (certain 'water tablets'), ACE inhibitors, angiotensin II receptor antagonists, NSAIDs (non steroidal anti-inflammatory medicines, e.g. aspirin or ibuprofen), heparin, immunosuppressives (e.g. cyclosporin or tacrolimus), and the antibiotic trimethoprim.
Slovenian: • zdravila, ki lahko povečajo raven kalija v krvi, na primer nadomestki soli s kalijem, diuretiki, ki zadržujejo kalij (nekatere tablete za odvajanje vode); zaviralci ACE, antagonisti receptorjev angiotenzina II, nesteroidna protivnetna zdravila (na primer acetilsalicilna kislina ali ibuprofen), heparin, imunosupresivi (na primer ciklosporin ali takrolimus) in antibiotik trimetoprim,
English: Exposure to angiotensin II receptor antagonist therapy during the second and third trimesters is known to induce human fetotoxicity (decreased renal function, oligohydramnios, skull ossification retardation) and neonatal toxicity (renal failure, hypotension, hyperkalaemia).
Slovenian: Znano je, da izpostavljenost antagonistom angiotenzina II v drugem in tretjem trimesečju nosečnosti lahko povzroči fetotoksične učinke pri človeku (zmanjšano delovanje ledvic, oligohidramnij,
English: Telmisartan does not inhibit angiotensin converting enzyme (kininase II), the enzyme which also degrades bradykinin.
Slovenian: Ne zavira angiotenzinske konvertaze (kininaze II) - encima, ki tudi razgrajuje bradikinin, zato predvidoma ne poveča neželenih učinkov, katere povzroča bradikinin.
English: Pritor 40 mg and 80 mg tablets
Slovenian: Pritor 40 mg in 80 mg tablete
English: Pritor 20 mg tablets
Slovenian: Pritor 20 mg tablete
English: Blood creatinine increased
Slovenian: Občasni zvišana raven kreatinina
English: Pritor 80 mg tablets
Slovenian: Pritor 80 mg tablete
English: The blood pressure lowering effect of telmisartan can be increased by concomitant use of other antihypertensive medicinal products.
Slovenian: Sočasno jemanje drugih antihipertenzivov lahko poveča telmisartanov antihipertenzivni učinek.
English: Pritor 80 mg tablets White oblong tablets of 4.6 mm engraved with the code number '52H' on one side.
Slovenian: Bele, 4,6 mm podolgovate tablete z vtisnjeno kodno številko 52H na eni strani.
English: You should store your medicine in the original package in order to protect the tablets from moisture.
Slovenian: Zdravilo shranjujte v originalni ovojnini za zagotovitev zaščite pred vlago.
English: Hepatic function abnormal/liver disorder Skin and subcutaneous tissue disorders Uncommon: Rare:
Slovenian: Bolezni jeter, žolčnika in žolčevodov Redki:
English: Therefore, in these patients an appropriate blood glucose monitoring should be considered; a dose adjustment of insulin or antidiabetics may be required, when indicated.
Slovenian: Če za to obstaja indikacija, je včasih treba prilagoditi odmerek insulina ali peroralnega antidiabetika.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton
Slovenian: PODATKI NA ZUNANJI OVOJNINI Škatla
English: There is an increased risk of severe hypotension and renal insufficiency when patients with bilateral renal artery stenosis or stenosis of the artery to a single functioning kidney are treated with medicinal products that affect the renin-angiotensin-aldosterone system.
Slovenian: Pri bolnikih z obojestransko zožitvijo ledvične arterije ali zožitvijo arterije samo ene delujoče ledvice zdravljenje z zdravili, ki delujejo na renin-angiotenzin-aldosteronski sistem, poveča nevarnost hude hipotenzije in zmanjšanja delovanja ledvic.
English: NAME OF THE MEDICINAL PRODUCT Pritor 80 mg tablets telmisartan
Slovenian: IME ZDRAVILA Pritor 80 mg tablete telmisartan
English: Symptomatic hypotension, especially after the first dose of Pritor, may occur in patients who are volume and/or sodium depleted by vigorous diuretic therapy, dietary salt restriction, diarrhoea, or vomiting.
Slovenian: Pri bolnikih z zmanjšanim volumnom krvi in/ali zmanjšano količino natrija zaradi intenzivnega diuretičnega zdravljenja, omejitve količine soli v hrani, driske ali bruhanja, se zlasti po prvem odmerku zdravila Pritor lahko pojavi simptomatska hipotenzija.
English: NAME OF THE MEDICINAL PRODUCT Pritor 40 mg tablets telmisartan
Slovenian: IME ZDRAVILA Pritor 40 mg tablete telmisartan
English: How to store Pritor
Slovenian: Shranjevanje zdravila Pritor
English: A combination with ACE inhibitors or NSAIDs, for example, presents a lesser risk provided that precautions for use are strictly followed.
Slovenian: Zlasti veliko je pri kombinaciji z diuretiki, ki zadržujejo kalij, in če jih kombiniramo z nadomestki soli s kalijem.Na primer kombinacija z zaviralci ACE ali nesteroidnimi protivnetnimi zdravili je manj tvegana, če natančno upoštevamo previdnostne ukrepe za uporabo.
English: NAME OF THE MEDICINAL PRODUCT Pritor 20 mg tablets telmisartan
Slovenian: IME ZDRAVILA Pritor 20 mg tablete telmisartan
English: EU/1/98/089/011 (14 tablets) EU/1/98/089/012 (28 tablets) EU/1/98/089/020 (30 tablets) EU/1/98/089/013 (56 tablets) EU/1/98/089/019 (90 tablets) EU/1/98/089/014 (98 tablets)
Slovenian: EU/1/98/089/011 (14 tablet) EU/1/98/089/012 (28 tablet) EU/1/98/089/020 (30 tablet) EU/1/98/089/013 (56 tablet) EU/1/98/089/019 (90 tablet) EU/1/98/089/014 (98 tablet)
English: Each 20 mg tablet contains 84 mg sorbitol (E420).
Slovenian: Pomožne snovi z znanim učinkom Ena 20 mg tableta vsebuje 84 mg sorbitola (E420).
English: Tell your doctor if you are breast-feeding or about to start breast-feeding.
Slovenian: Obvestite zdravnika, če menite, da ste noseči ali načrtujete zanositev.
English: Urinary tract infections, upper respiratory tract infections (e.g. sore throat, inflamed sinuses, common cold), deficiency in red blood cells (anaemia), high potassium levels, difficulty falling asleep, feeling sad (depression), fainting (syncope), feeling of spinning (vertigo), slow heart rate (bradycardia), low blood pressure (hypotension) in users treated for high blood pressure, dizziness on standing up (orthostatic hypotension), shortness of breath, cough, abdominal pain, diarrhoea, discomfort in the abdomen, bloating, vomiting, itching, increased sweating, drug rash, back pain, muscle cramps, muscle pain (myalgia), kidney impairment including acute kidney failure, pain in the chest, feeling of weakness, and increased level of creatinine in the blood.
Slovenian: Občasni neželeni učinki (pojavijo se lahko pri največ 1 od 100 bolnikov): okužbe sečil, okužbe zgornjih dihal (npr. bolečine v grlu, vneti sinusi, prehlad), pomanjkanje rdečih krvničk (anemija), visoka raven kalija, težave z uspavanjem, občutek žalosti (depresija), omedlevica (sinkopa), vrtoglavica, počasen srčni utrip (bradikardija), nizek krvni tlak (hipotenzija) pri osebah, ki se zdravijo zaradi visokega krvnega tlaka, omotica pri vstajanju (ortostatska hipotenzija), zasoplost, kašelj, trebušne bolečine, driska, nelagodje v trebuhu, napenjanje, bruhanje, srbež, povečano znojenje, medikamentni izpuščaj, bolečine v hrbtu, mišični krči, mišična bolečina (mialgija), ledvična okvara, tudi akutna ledvična odpoved, bolečina v prsnem košu, občutek oslabelosti in zvišana raven kreatinina v krvi.
English: There was evidence for a benefit of telmisartan compared to placebo in the pre-specified secondary composite endpoint of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke [0.87 (95 % CI 0.76 - 1.00, p = 0.048)].
Slovenian: Podatki dokazujejo korist zdravljenja s telmisartanom v primerjavi s placebom glede na vnaprej opredeljeni sekundarni sestavljeni opazovani dogodek, in sicer smrt zaradi srčnožilnega dogodka, neusodni miokardni infarkt in neusodno možgansko kap [0,87 (95-odstotni interval zaupanja 0,76 - 1,00, p = 0,048)], medtem ko korist pri srčnožilni umrljivosti ni bila dokazana (razmerje tveganja 1,03, 95-odstotni interval zaupanja 0,85
English: Sepsis* (often called "blood poisoning", is a severe infection with whole-body inflammatory response which can lead to death), increase in certain white blood cells (eosinophilia),low platelet count (thrombocytopenia), severe allergic reaction (anaphylactic reaction), allergic reaction (e.g. rash, itching, difficulty breathing, wheezing, swelling of the face or low blood pressure), low blood sugar levels (in diabetic patients), feeling anxious, somnolence, impaired vision, fast heart beat (tachycardia), dry mouth, upset stomach, taste disturbance (dysgeusia), abnormal liver function (Japanese patients are more likely to experience this side effect) , rapid swelling of the skin and mucosa which can also lead to death (angioedema also with fatal outcome), eczema (a skin disorder), redness of skin, hives (urticaria), severe drug rash, , joint pain (arthralgia), pain in extremity, tendon pain, flu-like-illness, decreased haemoglobin (a blood protein), increased levels of uric acid, increased hepatic enzymes or creatine phosphokinase in the blood.
Slovenian: Redki neželeni učinki (pojavijo se lahko pri največ 1 od 1.000 bolnikov): sepsa* (pogosto poimenovana tudi zastrupitev krvi, je huda okužba, pri kateri pride v vsem telesu do vnetnega odziva in je lahko usodna), povečanje določenih belih krvničk (eozinofilija), majhno število trombocitov (trombocitopenija), huda alergijska reakcija (anafilaktična reakcija), alergijska reakcija (npr. izpuščaj, srbež, oteženo dihanje, piskanje, otekanje obraza ali nizek krvni tlak), nizka raven krvnega sladkorja (pri bolnikih s sladkorno boleznijo), občutek tesnobe, zaspanost, motnje vida, hitro bitje srca (tahikardija), suha usta, želodčne težave, motnje okusa (disgevzija), motnje v delovanju jeter (pri japonskih bolnikih obstaja večja verjetnost pojavljanja tega neželenega učinka), hitro otekanje kože in sluznice, ki lahko povzroči tudi smrt (angioedem tudi s smrtnim izidom), ekcem (kožno obolenje), kožna rdečica, izpuščaji (urtikarija), hud medikamentni izpuščaj, bolečina v sklepih (artralgija), bolečina v okončini, bolečina v kitah, gripi podobna bolezen, znižan hemoglobin (krvna beljakovina), povečana raven sečne kisline, povečana raven jetrnih encimov ali kreatin fosfokinaze v krvi.
English: There is an apparent trend to a dose relationship to a time to recovery of baseline systolic blood pressure (SBP).
Slovenian: Rezultati študij kažejo na nakazano povezanost med odmerkom in časom, v katerem se povrnejo začetne vrednosti sistoličnega krvnega tlaka.
English: Unless continued angiotensin II receptor antagonist therapy is considered essential, patients planning pregnancy should be changed to alternative antihypertensive treatments which have an established safety profile for use in pregnancy.
Slovenian: Pri bolnicah, ki načrtujejo nosečnost, je treba čimprej preiti na alternativno antihipertenzivno zdravljenje z uveljavljenim varnostnim profilom za uporabo v nosečnosti; razen, če se oceni, da je nadaljnje zdravljenje z antagonisti angiotenzina II nujno.
English: EU/1/98/089/006 (14 tablets) EU/1/98/089/007 (28 tablets) EU/1/98/089/022 (30 tablets) EU/1/98/089/008 (56 tablets) EU/1/98/089/018 (90 tablets) EU/1/98/089/009 (98 tablets) EU/1/98/089/010 (280 tablets) EU/1/98/089/016 (28 x 1 tablets)
Slovenian: EU/1/98/089/006 (14 tablet) EU/1/98/089/007 (28 tablet) EU/1/98/089/022 (30 tablet) EU/1/98/089/008 (56 tablet) EU/1/98/089/018 (90 tablet) EU/1/98/089/009 (98 tablet) EU/1/98/089/010 (280 tablet) EU/1/98/089/016 (28 x 1 tableta)
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 40 mg telmisartan.
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN 1 tableta vsebuje 40 mg telmisartana.
English: EU/1/98/089/001 (14 tablets) EU/1/98/089/002 (28 tablets) EU/1/98/089/021 (30 tablets) EU/1/98/089/003 (56 tablets) EU/1/98/089/017 (90 tablets) EU/1/98/089/004 (98 tablets) EU/1/98/089/005 (280 tablets) EU/1/98/089/015 (28 x 1 tablets)
Slovenian: EU/1/98/089/001 (14 tablet) EU/1/98/089/002 (28 tablet) EU/1/98/089/021 (30 tablet) EU/1/98/089/003 (56 tablet) EU/1/98/089/017 (90 tablet) EU/1/98/089/004 (98 tablet) EU/1/98/089/005 (280 tablet) EU/1/98/089/015 (28 x 1 tableta)
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 20 mg telmisartan.
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN 1 tableta vsebuje 20 mg telmisartana.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 80 mg telmisartan.
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN 1 tableta vsebuje 80 mg telmisartana.
English: Most cases of hepatic function abnormal / liver disorder from post-marketing experience occurred in Japanese patients.
Slovenian: O večini primerov nenormalnega delovanja jeter ali jetrne bolezni so v obdobju po začetku trženja telmisartana poročali pri japonskih bolnikih, pri katerih tudi sicerobstaja večja verjetnost teh neželenih reakcij.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Blister of 7 tablets
Slovenian: Pretisni omot za enkratni odmerek ali vsi tisti pretisni omoti, ki ne vsebujejo po 7 tablet
English: To be taken into account with concomitant use.
Slovenian: Sočasno zdravljenje, ki ga je treba upoštevati.
English: What Pritor looks like and contents of the pack Pritor 40 mg tablets are white, oblong-shaped and engraved with the code '51H' on one.
Slovenian: Tablete Pritor 40 mg so bele, podolgovate tablete z vtisnjeno kodno številko 51H.
English: Marketing Authorisation Holder Bayer AG
Slovenian: Imetnik dovoljenja za promet z zdravilom Bayer AG
English: The European Commission granted a marketing authorisation valid throughout the European Union for Insuman on 21 February 1997.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Insuman, veljavno po vsej Evropski uniji, odobrila dne 21. februarja 1997.
English: The pump must not be implanted in people who reside permanently at elevations above at elevations above 2,439 metres (8000 feet).
Slovenian: Črpalka se ne sme vsaditi pri ljudeh, ki stalno prebivajo na nadmorski višini nad 2 439 metrov (8000 čevljev).
English: The full EPAR for Insuman can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Insuman je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Insuman should be given before meals.
Slovenian: Zdravilo Insuman je treba dajati pred obrokom.
English: Insuman human insulin
Slovenian: Insuman humani insulin
English: What benefit has Insuman shown during the studies?
Slovenian: Kakšne koristi je zdravilo Insuman izkazalo med študijami?
English: The injection site is changed for each injection.
Slovenian: Mesto injiciranja je treba pri vsaki injekciji spremeniti.
English: This is a summary of the European public assessment report (EPAR) for Insuman.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Insuman.
English: No other insulins must be used with the pump and the pump must not be used in children who have not yet reached adult size.
Slovenian: S črpalko se ne sme uporabiti nobenega drugega insulina, črpalka pa se ne sme uporabiti pri otrocih, ki še niso dosegli velikosti odraslih.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Insuman.
Slovenian: Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil zdravilo Insuman, na podlagi česar je oblikoval mnenje za odobritev dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
English: The Insuman range is comprised of:
Slovenian: Izdelki Insuman vključujejo:
English: Insuman Rapid may also be given into a vein, but only in an intensive care unit or similar setting where the patient can be closely monitored.
Slovenian: Zdravilo Insuman Rapid se lahko daje tudi v veno, vendar le na oddelku za intenzivno nego ali v podobnem okolju, kjer je mogoče bolnika natančno nadzorovati.
English: By controlling the level of blood glucose, the symptoms and complications of diabetes are reduced.
Slovenian: Z uravnavanjem ravni glukoze v krvi se simptomi in zapleti, povezani s sladkorno boleznijo, zmanjšajo.
English: Other information about Insuman
Slovenian: Druge informacije o zdravilu Insuman
English: What is the risk associated with Insuman?
Slovenian: Kakšna tveganja so povezana z zdravilom Insuman?
English: It must also not be used in patients who are hypersensitive to titanium alloy, polysulfone or silicone material used in the components of the implanted pump.
Slovenian: Prav tako se ne sme uporabljati pri bolnikih, ki so preobčutljivi za titanovo zlitino, polisulfonske ali silikonske materiale, uporabljene v sestavnih delih vsajene črpalke.
English: The main measure of effectiveness in all studies was the change in the level of glycosylated haemoglobin (HbA1c), which is the percentage of haemoglobin in the blood that has glucose attached.
Slovenian: Glavno merilo učinkovitosti v vseh študijah je bila sprememba ravni glikoziliranega hemoglobina (HbA1c), kar je odstotek hemoglobina v krvi, na katerega je vezana glukoza.
English: For more information about treatment with Insuman, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Insuman preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: Insuman may cause hypoglycaemia.
Slovenian: Zdravilo Insuman lahko povzroči hipoglikemijo.
English: Insuman must not be used in people who are hypersensitive (allergic) to human insulin or any of the other ingredients.
Slovenian: Zdravila Insuman ne smejo uporabljati osebe, ki so preobčutljive za (alergične na) humani insulin ali katero koli drugo sestavino zdravila.
English: See the package leaflet for exact timings.
Slovenian: Za natančen čas dajanja glejte navodilo za uporabo.
English: Why has Insuman been approved?
Slovenian: Zakaj je bilo zdravilo Insuman odobreno?
English: The active substance in Insuman, human insulin, is produced by a method known as ‘recombinant DNA technology': it is made by bacteria into which a gene (DNA) has been introduced that makes the bacteria able to produce insulin.
Slovenian: Zdravilna učinkovina zdravila Insuman, humani insulin, se proizvaja z metodo, znano kot „tehnologija rekombinantne DNK“, pri kateri se v bakterije vstavi gen (DNK), s katerim lahko tvorijo insulin.
English: The replacement insulin acts in the same way as naturally produced insulin and helps glucose enter cells from the blood.
Slovenian: Nadomestni insulin deluje enako kot naravno proizvedeni insulin in omogoča, da lahko glukoza iz krvi preide v celice.
English: The Committee recommended that Insuman be given marketing authorisation.
Slovenian: Priporočil je, da se za zdravilo Insuman odobri dovoljenje za promet.
English: • Insuman Comb, which is available in various combinations of fast- and intermediate-acting insulins.
Slovenian: • Insuman Comb, ki je na voljo v različnih kombinacijah insulina s hitrim in srednje dolgim delovanjem.
English: Insuman is used in patients with diabetes (type 1 and 2) who need treatment with insulin.
Slovenian: Zdravilo Insuman se uporablja pri bolnikih s sladkorno boleznijo (tipa 1 in tipa 2), ki potrebujejo zdravljenje z insulinom.
English: Insuman contains insulin in various forms: the soluble form, which acts quickly (within 30 minutes of injection), and the isophane and crystalline-protamine forms, which are absorbed much more slowly during the day, giving them a longer duration of action.
Slovenian: Zdravilo Insuman vsebuje insulin v različnih oblikah: v topni obliki, ki učinkuje hitro (v 30 minutah po injiciranju), ter v „izofani“ in kristalni obliki s protaminom, ki se absorbira veliko počasneje v teku dneva ter posledično zagotavlja daljše trajanje učinkovanja.
English: Diabetes is a disease in which the body does not produce enough insulin to control the level of blood glucose (type 1 diabetes) or when the body is unable to use insulin effectively (type 2 diabetes).
Slovenian: Sladkorna bolezen je bolezen, pri kateri telo ne proizvaja dovolj insulina za vzdrževanje primerne ravni glukoze v krvi (sladkorna bolezen tipa 1) ali pri kateri telo insulina ne more učinkovito uporabljati (sladkorna bolezen tipa 2).
English: Further information on the way Insuman is given can be found in the Summary of Product Characteristics (also part of the EPAR).
Slovenian: Za dodatne informacije o načinu dajanja zdravila Insuman glejte povzetek glavnih značilnosti zdravila (ki je prav tako del EPAR).
English: These patients received Insuman Implantable as a continuous infusion into the peritoneal cavity.
Slovenian: Bolniki so zdravilo Insuman Implantable prejemali kot kontinuirano infuzijo v peritonealno votlino.
English: Insuman has been studied in three trials in 780 patients with either type 1 diabetes or type 2 diabetes.
Slovenian: Zdravilo Insuman so proučevali v treh študijah s 780 bolniki s sladkorno boleznijo tipa 1 ali tipa 2.
English: Insuman Implantable is used in adult patients with type 1 diabetes that cannot be controlled with insulin given under the skin and who often have episodes of, otherwise unexplained, hyper- or hypoglycaemia (high or low blood glucose levels).
Slovenian: Zdravilo Insuman Implantable se uporablja pri odraslih bolnikih s sladkorno boleznijo tipa 1, ki ga ni mogoče urediti z insulinom, danim pod kožo, in ki imajo pogosto epizode drugače nepojasnjene hiperali hipoglikemije (visoke ali nizke ravni glukoze v krvi).
English: Insuman Rapid, Infusat, Basal and Comb are given by injection under the skin, generally in the abdominal wall (tummy) or the thigh, according to the doctor's recommendations.
Slovenian: Zdravila Insuman Rapid, Infusat, Basal in Comb se dajejo z injekcijo pod kožo, običajno v trebušno steno ali stegno v skladu s priporočilom zdravnika.
English: Insuman Infusat is specially prepared ready to be used as a continuous infusion under the skin using an external portable infusion pump.
Slovenian: Zdravilo Insuman Infusat je posebej pripravljeno za uporabo kot kontinuirana infuzija pod kožo z uporabo zunanje prenosne infuzijske črpalke.
English: Insuman is a replacement insulin that is similar to the insulin made by the body.
Slovenian: Zdravilo Insuman je nadomestni insulin, ki je podoben insulinu, ki ga proizvaja telo.
English: In addition, Insuman Implantable was studied in adult patients with type 1 diabetes.
Slovenian: Poleg tega so zdravilo Insuman Implantable proučevali pri odraslih bolnikih s sladkorno boleznijo tipa 1.
English: For the full list of all side effects reported with Insuman, see the Package Leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Insuman, glejte navodilo za uporabo.
English: Insuman Rapid can also be used for the treatment of hyperglycaemic coma (coma caused by too much blood glucose [sugar]) and ketoacidosis (high levels of ketones [acids] in the blood), and to control blood glucose before, during or after an operation.
Slovenian: Zdravilo Insuman Rapid je primerno tudi za zdravljenje hiperglikemične kome (kome, pogojene s previsoko koncentracijo glukoze [sladkorja] v krvi) in ketoacidoze (visoke ravni ketonov [kislin] v krvi) ter za uravnavanje glukoze v krvi pred in med operacijo ter po njej.